Daily non-political popular news in brief.

Rx for heart failure: Patient-centered care from a pharmacist

05-14-2007 · EurekAlert!

Heart failure patients have fewer emergency room visits and hospital stays and take their medicine more reliably when under the care of a pharmacist trained in patient-centered care.

Keywords: heart, failure, patient-centered, care, pharmacist, patient, centered

« Previous | Next »

Similar news on "Rx for heart failure: Patient-centered care from a pharmacist":

Go team -- 2 kinds of teamwork improves care for chronic heart failure
02-02-2007 · EurekAlert!
Active patient involvement during treatment of chronic heart failure, coupled with partnership with healthcare team members to provide care consistent with evidence-based guidelines, dramatically improves quality of care for chronic heart failure patients according to a study by researchers from the Indiana University School of Medicine, the Regenstrief Institute and the Roudebush VA Medical Center.
Similar news · Read more »
Heart-failure patients benefit from pharmacist care
05-14-2007 · EurekAlert!
Heart-failure patients take their medicine more reliably when under the care of a pharmacist, resulting in fewer emergency-room visits and hospital stays as well as lower health-care costs, according to a study from the University of North Carolina at Chapel Hill School of Pharmacy.
Similar news · Read more »
Most hospital performance measures for heart failure not linked to improved patient outcomes
01-02-2007 · EurekAlert!
Four of five hospital performance measures for heart failure do not appear to accurately reflect the quality of care provided, according to a study in the Jan. 3 issue of JAMA.
Similar news · Read more »
Study finds limitations in publicly reported quality-of-care indicators for heart-failure patients
01-02-2007 · EurekAlert!
Researchers reported that all five standard hospital-based performance measures used to gauge quality-of-care for hospitalized heart-failure patients may not be the best benchmarks since none were significant predictors of patient mortality during the critical first 60 to 90 days immediately following hospital discharge.
Similar news · Read more »
New study reports improved treatment and reduced mortality for patients with heart failure
05-01-2007 · EurekAlert!
UCLA researchers tracked heart failure in-hospital patient trends from 2002 to 2004 for 285 hospitals nationwide and found significant changes in treatment patterns and quality-of-care indicators that paralleled improvements in clinical outcomes and mortality.
Similar news · Read more »
Initiative to improve heart failure care at nation's hospitals makes major gains
07-23-2007 · EurekAlert!
A national initiative designed to improve heart-failure patient care in hospitals proved effective at increasing hospital adherence to key quality-of-care performance measures and reducing the length of hospital stays for patients. It also resulted in favorable trends for in-hospital and post-discharge mortality rates.
Similar news · Read more »
Heart failure: Mayo Clinic reveals abnormality in filling of the heart is frequent culprit
11-07-2006 · EurekAlert!
Difficulties in the heart's ability to fill with blood are common causes of heart failure -- and appear to be as significant in placing a heart patient at risk of death as are deficiencies in the heart's ability to pump blood, new research from Mayo Clinic shows.
Similar news · Read more »
Implant device effectively maintains heart function for transplant-listed patients
03-27-2007 · EurekAlert!
Whether a patient is awaiting a heart transplant or living with chronic heart failure, cardiologists are continuously looking for new therapies that address short-term and/or long-term needs of chronically impaired cardiac patients. Research presented today at the American College of Cardiology's 56th Annual Scientific Session reviewed new treatments and interventions, including LVAD implantation and diuretic therapies to support left ventricular function in severely compromised cardiovascular patients.
Similar news · Read more »
Patient-centered approach can backfire
08-13-2007 · EurekAlert!
A University of Iowa study suggests that patients are most satisfied with care and most likely to follow treatment plans -- like taking medication or making diet changes -- if they see a doctor whose attitudes toward patient-physician roles are in line with their own.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »